Clinical Trial Update: Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC [Phase 2]

View source ↗

Summary

Phase 2 trial investigating LTC004 in combination with regorafenib for advanced/metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• LTC004 (LTC004)
• Regorafenib (regorafenib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Advanced/Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN